Related Experiment Video

Updated: Jul 5, 2026

Identification of Modified Histones as Binding Substrates of Human Spindlin Family Member 4 (SPIN4) by Peptide Arrays and Native Nucleosome Pulldown
09:34

Identification of Modified Histones as Binding Substrates of Human Spindlin Family Member 4 (SPIN4) by Peptide Arrays and Native Nucleosome Pulldown

Published on: March 27, 2026

Small molecules targeting histone H4 as potential therapeutics for chronic myelogenous leukemia

C James Chou1, Michelle E Farkas, Sherry M Tsai

  • 1Department of Molecular Biology, The Scripps Research Institute, La Jolla, California, USA.

Molecular Cancer Therapeutics
|April 17, 2008
PubMed

Insights

New polyamide-chlorambucil conjugates, 1R-Chl and 6R-Chl, effectively inhibit chronic myelogenous leukemia growth with low toxicity. These compounds target histone H4 genes, offering a potential new treatment for leukemia.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Polyamide-chlorambucil conjugates show promise in cancer treatment.
  • Histone H4 gene transcription is implicated in cancer cell growth.

Purpose of the Study:

  • To investigate the effects of polyamide-chlorambucil conjugates on chronic myelogenous leukemia (CML) K562 cell line.
  • To identify and characterize novel polyamide conjugates targeting H4 genes for CML therapy.

Main Methods:

  • Treatment of K562 cells and murine xenograft models with 1R-Chl and 6R-Chl.
  • Analysis of gene transcription and cellular response to polyamide conjugates.
  • Evaluation of in vitro and in vivo efficacy and toxicity.

Main Results:

  • 1R-Chl and 6R-Chl target H4 genes and inhibit K562 cell growth.
  • Both conjugates effectively blocked K562 xenograft growth in murine models.
  • Minimal cytotoxicity and animal toxicity were observed at therapeutic doses.

Conclusions:

  • Polyamide-chlorambucil conjugates targeting H4 genes are effective against CML.
  • These compounds demonstrate high-dose tolerance and low toxicity compared to conventional alkylators.
  • Polyamide alkylators represent a potential alternative treatment for chronic myelogenous leukemia.

More Related Videos

Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays11:17

Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays

Published on: June 13, 2019

Assays for Validating Histone Acetyltransferase Inhibitors09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Histone Variants at the Centromere02:30

Histone Variants at the Centromere

Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3 variants are also...
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer is an enzyme that can...